 |
|
| COMPREHENSIVE MEDICINAL CHEMISTRY II
| |
| | |
|
|
Volume 5: ADME-TOX APPROACHES
To order this title, and for more information, click here
Edited By
Bernard Testa, University Hospital Centre, Lausanne, Switzerland
Han van de Waterbeemd, AstraZeneca, Macclesfield, Cheshire, UK
Description
To be effective a drug must be Absorbed then Distributed to the site of action. It must also be Metabolised and Excreted without any
measurable Toxicity (ADMET). This volume examines major ADMET issues, tools to measure these properties in vivo and in vitro and in-silico
tools to predict and analyse effects. It concludes with a review of tools that can assist drug discovery in its early development stage.
Audience
For students and researchers in chemistry, biochemistry, medicinal chemistry and pharmacology and scientists working in the pharmaceutical industries.
Contents
Volume 5 ADME-Tox Approaches
Introduction
5.01 The Why and How of Absorption, Distribution, Metabolism, Excretion, and Toxicity
Research
Biological and In Vivo Aspects of Absorption, Distribution, Metabolism, Excretion, and Toxicity
5.02 Clinical Pharmacokinetic
Criteria for Drug Research
5.03 In Vivo Absorption, Distribution, Metabolism, and Excretion Studies in Discovery and Development
5.04
The Biology and Function of Transporters
5.05 Principles of Drug Metabolism 1: Redox Reactions
5.06 Principles of Drug Metabolism
2: Hydrolysis and Conjugation Reactions
5.07 Principles of Drug Metabolism 3: Enzymes and Tissues
5.08 Mechanisms of Toxification
and Detoxification which Challenge Drug Candidates and Drugs
5.09 Immunotoxicology
Biological In Vitro Tools in Absorption, Distribution,
Metabolism, Excretion, and Toxicity
5.10 In Vitro Studies of Drug Metabolism
5.11 Passive Permeability and Active Transport Models
for the Prediction of Oral Absorption
5.12 Biological In Vitro Models for Absorption by Nonoral Routes
5.13 In Vitro Models for
Examining and Predicting Brain Uptake of Drugs
5.14 In Vitro Models for Plasma Binding and Tissue Storage
5.15 Progress in Bioanalytics
and Automation Robotics for Absorption, Distribution, Metabolism, and Excretion Screening
Physicochemical tools in Absorption, Distribution,
Metabolism, Excretion, and Toxicity
5.16 Ionization Constants and Ionization Profiles
5.17 Dissolution and Solubility
5.18 Lipophilicity,
Polarity, and Hydrophobicity
5.19 Artificial Membrane Technologies to Assess Transfer and Permeation of Drugs in Drug Discovery
5.20
Chemical Stability
5.21 Solid-State Physicochemistry
In Silico Tools in Absorption, Distribution, Metabolism, Excretion, and Toxicity
5.22
Use of Molecular Descriptors for Absorption, Distribution, Metabolism, and Excretion Predictions
5.23 Electrotopological State Indices
to Assess Molecular and Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties
5.24 Molecular Fields to Assess Recognition
Forces and Property Spaces
5.25 In Silico Prediction of Ionization
5.26 In Silico Predictions of Solubility
5.27 Rule-Based
Systems to Predict Lipophilicity
5.28 In Silico Models to Predict Oral Absorption
5.29 In Silico Prediction of Oral Bioavailability
5.30
In Silico Models to Predict Passage through the Skin and Other Barriers
5.31 In Silico Models to Predict Brain Uptake
5.32 In Silico
Models for Interactions with Transporters
5.33 Comprehensive Expert Systems to Predict Drug Metabolism
5.34 Molecular Modeling
and Quantitative Structure?Activity Relationship of Substrates and Inhibitors of Drug Metabolism Enzymes
5.35 Modeling and Simulation
of Pharmacokinetic Aspects of Cytochrome P450-Based Metabolic Drug?Drug Interactions
5.36 In Silico Prediction of Plasma and Tissue
Protein Binding
5.37 Physiologically-Based Models to Predict Human Pharmacokinetic Parameters
5.38 Mechanism-Based Pharmacokinetic?Pharmacodynamic
Modeling for the Prediction of In Vivo Drug Concentration?Effect Relationships – Application in Drug Candidate Selection and Lead Optimization
5.39
Computational Models to Predict Toxicity
5.40 In Silico Models to Predict QT Prolongation
5.41 The Adaptive In Combo Strategy
Enabling
Absorption, Distribution, Metabolism, Excretion, and Toxicity Strategies and Technologies in Early Development
5.42 The Biopharmaceutics
Classification System
5.43 Metabonomics
5.44 Prodrug Objectives and Design
5.45 Drug?Polymer Conjugates
| Bibliographic details |
Hardbound, 1181 pages, publication date: NOV-2006
ISBN-13: 978-0-08-044518-2
ISBN-10: 0-08-044518-7
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 285
USD 495
EUR 325
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
030/302
Last update: 5 Sep 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company